HCA Healthcare
Q2 2022 Earnings Call
Jul 22, 2022, 9:00 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Welcome to the HCA Healthcare second quarter 2022 earnings conference call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to vice president of investor relations, Mr. Frank Morgan.
Please go ahead, sir.
Frank Morgan -- Vice President, Investor Relations
Good morning, and welcome to everyone on today's call. With me this morning is our CEO, Sam Hazen; and CFO, Bill Rutherford. Sam and Bill will provide some prepared remarks, and then we'll take questions. Before I turn the call over to Sam, let me remind everyone that should today's call contain any forward-looking statements, they are based on management's current expectations.
Numerous risks, uncertainties, and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors are listed in today's press release and in our various SEC filings. On this morning's call, we may refer -- we may reference measures such as adjusted EBITDA, which is a non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc.
is included in today's release. This morning's call is being recorded, and a replay of the call will be available later today. With that, I'll now turn the call over to Sam.
Sam Hazen -- Chief Executive Officer
All right. Thank you, Frank, and good morning to everybody. Thank you for joining today's call. We are pleased with our financial results for the second quarter.
The solid results were driven by a good mix of volume with respect to payer mix and acuity coupled with progress in managing our operating costs. Although overall demand for our services was not as strong as anticipated when compared to the second quarter of last year, same facility revenue grew 4%. As indicated in our earnings release, same-facility inpatient admissions declined 1.2% and adjusted admissions grew 0.5%. COVID admissions declined 18% and represented approximately 3% of total admissions, which is generally consistent with the mix in the prior year.
COVID admissions dropped 70% from the first quarter. Emergency were admitted on a same facilities basis grew 7.3%, reflecting strong demand for this service. Volumes across most categories exceeded pre-pandemic levels as compared to the second quarter of 2019. Many aspects of our business were positive considering the challenges we faced with the labor market and the other inflationary pressures on costs.